MARKET

CLNNW

CLNNW

Clene
NASDAQ
0.0093
+0.0013
+16.25%
Closed 15:22 12/05 EST
OPEN
0.0095
PREV CLOSE
0.0080
HIGH
0.0095
LOW
0.0052
VOLUME
1.30K
TURNOVER
--
52 WEEK HIGH
0.0513
52 WEEK LOW
0.0040
MARKET CAP
--
P/E (TTM)
-0.0028
1D
5D
1M
3M
1Y
5Y
1D
Clene Reports Statistically Significant ALS Biomarker Results for CNM-Au8 Supporting Accelerated FDA Approval Pathway
Reuters · 3d ago
CLENE ANNOUNCES STATISTICALLY SIGNIFICANT ALS BIOMARKER RESULTS SUPPORTING ACCELERATED APPROVAL PATHWAY FOR CNM-AU8®
Reuters · 3d ago
Clene Inc. Announces CNM-Au8 ALS Program Update Webcast
Reuters · 4d ago
CLENE TO PROVIDE CNM-AU8® ALS PROGRAM UPDATE
Reuters · 4d ago
Weekly Report: what happened at CLNNW last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at CLNNW last week (1117-1121)?
Weekly Report · 11/24 09:55
Clene Inc. to Join Benchmark 14th Annual Discovery One-on-One Investor Conference
Reuters · 11/20 13:00
Weekly Report: what happened at CLNNW last week (1110-1114)?
Weekly Report · 11/17 09:54
More
About CLNNW
Clene Inc. is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson's disease and multiple sclerosis. It specializes in the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its CNM-Au8 is an investigational first-in-class therapy that improves central nervous system cells' survival and function via a mechanism that targets mitochondrial function and the nicotinamide adenine dinucleotide pathway while reducing oxidative stress. Its CNM-ZnAg is a broad-spectrum antiviral, antibacterial agent comprised of zinc (Zn2+) and silver (Ag+) ions under development to treat infectious disease and to provide immune support for symptom resolution. Its CNM-AgZn17 is a gel polymer suspension of Zn2+ and Ag+ under development for treatment of infectious diseases and to support wound healing.

Webull offers Clene Inc. stock information, including NASDAQ: CLNNW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLNNW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLNNW stock methods without spending real money on the virtual paper trading platform.